Skip to main content
Premium Trial:

Request an Annual Quote

Analytik Jena's Life Science Q1 Revenues Rise 45 Percent

NEW YORK (GenomeWeb News) – Analytik Jena today reported that its fiscal first quarter life science revenues rose 45 percent year over year as its total revenues climbed 33 percent.

The German analytical instruments firm reported total revenues of €32.4 million for the three months ended Dec. 31, 2013, compared to €24.3 million for Q1 2013. Its Analytical Instrumentation business saw sales decline around 13 percent to €13.8 million from €15.8 million, while Life Science sales rose 45 percent to €10.7 million from €7.4 million. Its Optics business generated revenues of €1.2 million in the quarter, flat with the first quarter of 2013.

The firm said that its Life Science business was boosted by sales for its UVP subsidiary and CyBio, which makes the CyBio HTRF workstation, a customized, modular automation platform for high-throughput applications.

Analytik Jena reported a Q1 consolidated net loss of €215,000, or €.03 per share, compared to a net loss of €64,000, or €.03 per share, for Q1 2013.

The firm finished the quarter with €28.7 million in cash and cash equivalents.